Publikationen 2025

Ackermann G., Peil M., Quarz C., Schmidt A., Halaczkiewicz M., Thomas A.D., Stegmüller S., Richling E., Manolikakes G., Christmann M., Küpper J.H., Schrenk D., Fahrer J. (2025) Molecular dosimetry of estragole and 1'-hydroxyestragole-induced DNA adduct formation, clastogenicity and cytotoxicity in human liver cell models, Archives of Toxicology, pub ahead of print

Switzeny O., Pusch S., Christmann M., Kaina B. (2025) IDH1 mutation impacts DNA repair through ALKBH2 rendering glioblastoma cells sensitive to artesunate, Biomedicines, 13, 1479

Schwarzenbach C., Rinke j., Vilar J.B., Sallbach J., Tatsch L., Schmidt A., Schöneis A., Rasenberger B., Kaina B., Tomicic M.T., Christmann M. (2025) Therapy-induced senescence of glioblastoma cells is determined by the p21cip1-CDK1/2 axis and does not require activation of DREAM, CDD press Springer Nature, (pub ahead of print).

Jungwirth J., Mieland A.O., Piée-Staffa A., Heimburg T., Brenner W., Ehrhardt C., Sippl W., Henke A., Krämer O.H. (2025) Pharmacologically induced proteolysis of histone deacetylase-6 attenuates influenza virus replication despite limited anti-tumor effects, Life Sciences (e-pub ahead of print).

Haas B., Roth I., Säcker L., Wos-Maganga M., Beltzig L., Kaina B. (2025) Apoptotic and senolytic effects of hERG/Eag1 channel blockers in combination with temozolomide in human glioblastoma cells, Naunyn-Schmiedeberg's Archives of Pharmacology (e-pub ahead of print).

Fincke V.E., Sax I., Kunstreich M., Golas M.M., Hofmann T.G., Schlesner M., Claus R., Redlich A., Johann P.D., Kuhlen M. (2025) Double heterozygous pathogenic variants in BRCA2 and CHEK2 in a girl with adrenocortical carcinoma, Exploration of Endocrine and Metabolic Diseases, 2: 101429